According to the latest report by IMARC Group, titled “Cough Syrup Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, the global cough syrup market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/cough-syrup-market/requestsample
Cough syrup is a medicated liquid consumed orally to provide relief from common cold, cough, fever and allergies. Expectorants, combination medications and cough suppressants are some commonly available variants of cough syrups. They are manufactured using eucalyptus oil, menthol, dextromethorphan (DM) and non-opioid cough suppressants. Cough syrups exhibit anti-allergic properties and consist of mucolytic agents that aid in thinning and loosening of mucus in the airways. They also ease the breath, reduce the urge to cough and clear congestion. Cough syrups are widely used by adults and children and are conveniently available over the counter.
The global cough syrup market is primarily being driven by the rising incidence of chronic and acute respiratory diseases. Cough syrups are widely used to treat upper respiratory tract infection (URTI), asthma and other respiratory disorders. Moreover, the introduction of cough syrups with natural and organic herbs and immunity-boosting ingredients with minimal side effects is providing a thrust to the market growth. Other factors, including the rising geriatric population, along with the rapidly increasing air pollution levels, are anticipated to drive the market toward growth.
Cough Syrup Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global cough syrup market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Acella Pharmaceuticals LLC
- Bayer AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Reckitt Benckiser Group PLC
- Sanofi
- Sun Pharmaceutical Industries Limited
- The Procter & Gamble Company
Key Market Segmentation:
The report has segmented the global cough syrup market on the basis of product type, age group, distribution channel and region.
Breakup by Product Type:
- Expectorants
- Cough Suppressants/Antitussives
- Combination Medications
Breakup by Age Group:
- Pediatric
- Adult
Breakup by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/cough-syrup-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
